Latest Articles
Outlook for endometriosis: Progression, treatment success, and more - MedicalNewsToday
Outlook for endometriosis: Progression, treatment success, and more MedicalNewsToday
Published: Dec. 9, 2025, 2:13 p.m.
Additional treatment option for endometriosis now available - Pharmacy Today
Additional treatment option for endometriosis now available Pharmacy Today
Published: Dec. 9, 2025, 11:34 a.m.
Farmington lab brings researchers, policy makers to improve endometriosis treatment - WTNH.com
Farmington lab brings researchers, policy makers to improve endometriosis treatment WTNH.com
Published: Dec. 8, 2025, 9:47 p.m.
Bayer launches phase III trial testing Mirena for uterine condition with no treatments - Indian Pharma Post
Bayer launches phase III trial testing Mirena for uterine condition with no treatments Indian Pharma Post
Published: Dec. 7, 2025, 6:02 a.m.
High cost of infertility treatments puts financial strain on couples: ICMR-NIRRCH study - The Hindu
High cost of infertility treatments puts financial strain on couples: ICMR-NIRRCH study The Hindu
Published: Dec. 5, 2025, 5:15 p.m.
Hematuria Treatment Market Size, Share & Growth Report by 2034 - Straits Research
Hematuria Treatment Market Size, Share & Growth Report by 2034 Straits Research
Published: Dec. 4, 2025, 1:45 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - BioSpace
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia BioSpace
Published: Dec. 3, 2025, 2:11 p.m.
United States Endometriosis Treatment Market Size, Share, - openPR.com
United States Endometriosis Treatment Market Size, Share, openPR.com
Published: Dec. 3, 2025, 6:59 a.m.
Why Patients Travel Across Europe for Deep Endometriosis Treatment - Medical Tourism Magazine
Why Patients Travel Across Europe for Deep Endometriosis Treatment Medical Tourism Magazine
Published: Dec. 3, 2025, 6:46 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com
Published: Dec. 3, 2025, 5:04 a.m.
Link copied to clipboard!